3 teams,
3 discoveries,
one paradigm shift

Faeth was born from three leading research teams with three separate discoveries coming together around one big idea: We can use metabolism to beat cancer.

The science of cancer meets the power of metabolism

Cancer therapies have remained largely unchanged for decades. At Faeth, we believe that the use of metabolism and precision nutrition will join surgery, radiotherapy, small molecules, and biologics as a foundational treatment for cancer.

Faeth is a data-driven, evidence-based company with a deep mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. Our discovery platform matches tumor genotypes with treatment regimens combining therapeutic targets and precision diets to improve patient outcomes. We are in clinical trials now.

3 teams,
3 discoveries,
1 paradigm shift

Faeth was born from three leading research teams with three separate discoveries coming together around one big idea: We can use metabolism to beat cancer.

Cancer therapies have remained largely unchanged for decades. At Faeth, we believe that the use of metabolism will be a foundational treatment for cancer.

Faeth is a data-driven, evidence-based company with a deep mechanistic understanding of the way that nutrients influence tumor growth and cancer treatment. Our discovery platform matches tumor genotypes with treatment regimens combining therapeutic targets and precision metabolic optimization to improve patient outcomes.

Our team of world-leading scientists and founders

FAETH
Alan Sun
Head of Product
Previously Head of Product at Curebase
Anand Parikh, JD
CEO & Co-Founder
Previously CFO at Virta Health
Chandrasekhar Mothali
Head of Engineering
Previously Engineering Manager at Flatiron Health
Debbie Chirnomas, MD MPH
Chief Medical Officer
Leader in clinical development, previously at Arvinas, Gamida Cell, Pfizer
Farzana Walcott, MD MPH
Executive Medical Director
Previously Senior Medical Director, New Indications, GI and GYN Oncology at Novocure
Oliver Maddocks, PhD
Chief Scientific Officer & Co-Founder
Previously Professor of Cancer Biology & Metabolism, University of Glasgow
Ryan Whitney
Head of Finance, Strategy, & Operations
Previously Strategic Finance Lead at Virta Health
Tina Niazi
Head of Clinical Operations
Previously Executive Director of Clinical Operations at Iovance Biotherapeutics
Anand Parikh, JD
Former CFO at Virta Health
Ben Hopkins, PhD
Asst. Prof., Genetics Genomics & Oncological Sciences, Icahn School of Medicine at Mount Sinai New York
Greg Hannon, PhD
Director of CRUK Cambridge Institute
Karen Vousden, PhD
Chief Scientist of CRUK, Group Leader, Crick Institute, Director, Bristol Myers Squibb
Lew Cantley, PhD
Dana Farber Cancer Institute, Harvard; Founder: Agios (NASDAQ), Petra, Volastra
Marcus Goncalves, MD PhD
Asst. Prof., Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine New York
Oliver Maddocks, PhD
Former Professor of Cancer Biology & Metabolism, University of Glasgow
Scott Lowe, PhD
Chair of Cancer Biology & Genetics at Memorial Sloan Kettering, Founder: ORIC (NASDAQ)
Sid Mukherjee, MD PhD
Asst. Prof., Columbia, Pulitzer Prize Winner, Time 100 Most Influential People, Founder: Vor (NASDAQ)
Simon Knott, PhD
Asst. Prof., Biomedical Sciences & Associate Director, Center for Bioinformatics and Functional Genomics, Cedars Sinai Medical Center Los Angeles
Alex Morgan, MD PhD
Partner at Khosla Ventures
Anand Parikh, JD
CEO & Co-Founder of Faeth
Jayson Dallas, MD
CEO of Rivus Pharmaceuticals
Oliver Maddocks, PhD
Chief Scientific Officer & Co-Founder of Faeth
Robert Gould, PhD
Former CEO of Fulcrum Therapeutics
Stephen Hahn, MD
Former Commissioner of the FDA
Board observers
Dan Ripma
S2G Ventures
Chris Metallo
Bioengineering, Cancer Metabolism & Systemic Metabolism, UCSD
Heather Christofk, PhD
Associate Director of Basic and Translational Research, UCLA Johnson Comprehensive Cancer Center; Professor of Biological Chemistry, David Geffen School of Medicine at UCLA; Co-Director, UCLA Metabolomics Center

John Blenis
Pharmacologist, Weill Cornell
Josh Rabinowitz
Special Advisor to the CSO

Professor of Chemistry and the Lewis-Sigler Institute for Integrative Genomics at Princeton
Lydia Lynch
Immunology, Obesity & Diet, Harvard Medical School
Matthew Vander Heiden, MD PhD
Associate Professor of Biology, MIT; Associate Director, Koch Institute for Integrative Cancer Research
Ralph DeBerardinis, MD PhD
Investigator, Howard Hughes Medical Institute; Chief of the Division of Genetics and Metabolism in the Department of Pediatrics, UT Southwestern Medical Center
Thales Papagiannakopoulos
Cancer Metabolism, Preclinical Models of Cancer, NYU

faeth leadership team

Anand Parikh, JD
CEO & Co-Founder
Previously CFO at Virta Health
Oliver Maddocks, PhD
Chief Scientific Officer & Co-Founder
Previously Professor of Cancer Biology & Metabolism, University of Glasgow
Debbie Chirnomas, MD, MPH
Chief Medical Officer
Leader in clinical development, previously at Arvinas, Gamida Cell, Pfizer
Tina Niazi
Head of Clinical Operations
Previously Executive Director of Clinical Operations at Iovance Biotherapeutics
Ryan Whitney
Head of Food Operations
Previously Strategic Finance Lead at Virta Health
Chandrasekhar Mothali
Head of Engineering
Previously Engineering Manager at Flatiron Health
Farzana Walcott, MD MPH
Executive Medical Director
Previously Senior Medical Director, New Indications, GI and GYN Oncology at Novocure
Alan Sun
Head of Product
Previously Head of Product at Curebase

faeth FOUNDERS

Anand Parikh, JD
Former CFO at Virta Health
Oliver Maddocks, PhD
Former Professor of Cancer Biology & Metabolism, University of Glasgow
Lew Cantley, PhD
Dana Farber Cancer Institute, Harvard; Founder: Agios (NASDAQ), Petra, Volastra
Greg Hannon, PhD
Director of CRUK Cambridge Institute
Scott Lowe, PhD
Chair of Cancer Biology & Genetics at Memorial Sloan Kettering, Founder: ORIC (NASDAQ)
Sid Mukherjee, MD PhD
Asst. Prof., Columbia, Pulitzer Prize Winner, Time 100 Most Influential People, Founder: Vor (NASDAQ)
Karen Vousden, PhD
Chief Scientist of CRUK, Group Leader, Crick Institute, Director, Bristol Myers Squibb
Marcus Goncalves, MD PhD
Asst. Prof., Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine New York
Ben Hopkins, PhD
Asst. Prof., Genetics Genomics & Oncological Sciences, Icahn School of Medicine at Mount Sinai New York
Simon Knott, PhD
Asst. Prof., Biomedical Sciences & Associate Director, Center for Bioinformatics and Functional Genomics, Cedars Sinai Medical Center Los Angeles

Faeth Board members

Alex Morgan, MD PhD
Khosla Ventures
Anand Parikh, JD
CEO & Co-Founder
Dan Ripma
S2G Ventures
Jayson Dallas, MD
Rivus
Oliver Maddocks, PhD
Chief Scientific Officer & Co-Founder
Robert Gould, PhD
Khosla Ventures
Sanjeev Krishnan
S2G Ventures
Stephen Hahn, MD
Former Commissioner of the FDA

Faeth Scientific Advisory Board

John Blenis
Pharmacologist, Weill Cornell
Heather Christofk, PhD
Associate Director of Basic and Translational Research, UCLA Johnson Comprehensive Cancer Center; Professor of Biological Chemistry, David Geffen School of Medicine at UCLA; Co-Director, UCLA Metabolomics Center

Ralph DeBerardinis, MD PhD
Investigator, Howard Hughes Medical Institute; Chief of the Division of Genetics and Metabolism in the Department of Pediatrics, UT Southwestern Medical Center
Matthew Vander Heiden, MD PhD
Associate Professor of Biology, MIT; Associate Director, Koch Institute for Integrative Cancer Research
Lydia Lynch
Immunology, Obesity & Diet, Harvard Medical School
Chris Metallo
Bioengineering, Cancer Metabolism & Systemic Metabolism, UCSD
Thales Papagiannakopoulos
Cancer Metabolism, Preclinical Models of Cancer, NYU
Josh Rabinowitz
Special Advisor to the CSO
Professor of Chemistry and the Lewis-Sigler Institute for Integrative Genomics at Princeton